DXCM vs TMO · P/E 63, rev $2.50B vs P/E 24, rev $23.00B
DexCom Inc (DXCM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the DXCM and TMO stock pages for the full models.
Not investment advice.